The Patent Finder

Quatex N.V.

Also on record
Records under this name other than patents Quatex N.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to Quatex N.V.

PatentTitleStatus Expires Confidence
US 7,553,870Use of polyunsaturated fatty acid for the primary prevention of major cardiovascular events
Formerly held
Term ended
Term ended Sep 14, 2024 · From the USPTO record
Term endedTerm ended Sep 14, 2024From the USPTO record
US 6,586,407Injectable pharmaceutical formulations for partricin derivatives
Formerly held
Term ended
Term ended Dec 22, 2020 · From the USPTO record
Term endedTerm ended Dec 22, 2020From the USPTO record
US 6,121,244Antitumoral method by administration of partricin derivatives
Formerly held
Term ended
Term ended Feb 26, 2019 · From the USPTO record
Term endedTerm ended Feb 26, 2019From the USPTO record
US 6,143,726Complexes of N'-dimethylaminoacetylpartricin A dimethylaminoethylamide, or the salts thereof, and cholesterol 3-sulphate
Formerly held
Term ended
Term ended Jan 12, 2019 · From the USPTO record
Term endedTerm ended Jan 12, 2019From the USPTO record
US 5,296,597Amide derivatives of Partricin A & Partricin B
Formerly held
Term ended
Term ended no later than Mar 22, 2014 · Low confidence
Term endedTerm ended no later than Mar 22, 2014Low confidence
US 5,298,495Partricin derivatives
Formerly held
Term ended
Term ended no later than Mar 29, 2014 · Low confidence
Term endedTerm ended no later than Mar 29, 2014Low confidence
US 5,908,834Partricin derivatives in the prophylactic and/or curative treatment of fungal contamination of cell cultures and of tissues
Formerly held
Term ended
Term ended no later than Jun 1, 2019 · Low confidence
Term endedTerm ended no later than Jun 1, 2019Low confidence
US 5,914,321Antitumoral method by administration of partricin derivatives
Formerly held
Term ended
Term ended no later than Jun 22, 2019 · Low confidence
Term endedTerm ended no later than Jun 22, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited